Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Epilepsia|August 6, 2013
Development of new treatment approaches for epilepsy: unmet needs and opportunitiesJacqueline A French, H Steve White, Henrik Klitgaard, et al.
Epilepsy & Behavior : E&B|April 11, 2021
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic reviewBernhard J Steinhoff, Pavel Klein, Henrik Klitgaard, et al.
Epilepsia|March 21, 2020
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?Pavel Klein, Alon Friedman, Mustafa Q Hameed, et al.
Epilepsia|August 6, 2013
Issues related to development of antiepileptogenic therapiesAsla Pitkänen, Astrid Nehlig, Amy R Brooks-Kayal, et al.
Epilepsia|December 15, 2015
Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of actionJean-Marie Nicolas, Jonas Hannestad, Daniel Holden, et al.
EJNMMI Research|November 8, 2022
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2AMika Naganawa, Jean-Dominique Gallezot, Sjoerd J Finnema, et al.
Epilepsia|March 30, 2019
A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteersSjoerd J Finnema, Samantha Rossano, Mika Naganawa, et al.
Epilepsia|December 17, 2017
Commonalities in epileptogenic processes from different acute brain insults: Do they translate?Pavel Klein, Raymond Dingledine, Eleonora Aronica, et al.
Pageof 6